Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance.

Jesus Jimenez,Nicolas Kostelecky,Joshua D Mitchell,Kathleen W Zhang,Chieh-Yu Lin,Daniel J Lenihan,Kory J Lavine

Cardio-oncology (London, England)（2023）

Cited 0|Views24

No score

Abstract

While the Dallas criteria can identify a subset of ICI-associated myocarditis patients, quantification of macrophage abundance may expand the diagnostic role of EMB. Failure to meet the traditional Dallas Criteria should not exclude the diagnosis of myocarditis.

Translated text

Key words

Cardio-oncology,Immune checkpoint inhibitors,Macrophage,Myocarditis

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined